These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 2365005)
1. Long-term diazepam treatment produces changes in cholecystokinin receptor binding in rat brain. Harro J; Lang A; Vasar E Eur J Pharmacol; 1990 May; 180(1):77-83. PubMed ID: 2365005 [TBL] [Abstract][Full Text] [Related]
2. Anxiogenic-like action of caerulein, a CCK-8 receptor agonist, in the mouse: influence of acute and subchronic diazepam treatment. Harro J; Põld M; Vasar E Naunyn Schmiedebergs Arch Pharmacol; 1990; 341(1-2):62-7. PubMed ID: 2314484 [TBL] [Abstract][Full Text] [Related]
3. Targeted mutation of CCK2 receptor gene modifies the behavioural effects of diazepam in female mice. Raud S; Rünkorg K; Veraksits A; Reimets A; Nelovkov A; Abramov U; Matsui T; Bourin M; Volke V; Kõks S; Vasar E Psychopharmacology (Berl); 2003 Aug; 168(4):417-25. PubMed ID: 12709779 [TBL] [Abstract][Full Text] [Related]
4. [Assessment of afobazole effects on diazepam withdrawal-induced anxiety in rats]. Eksp Klin Farmakol; 2014; 77(4):6-9. PubMed ID: 25076752 [TBL] [Abstract][Full Text] [Related]
5. Rats with anxious or non-anxious type of exploratory behaviour differ in their brain CCK-8 and benzodiazepine receptor characteristics. Harro J; Kiivet RA; Lang A; Vasar E Behav Brain Res; 1990 Jun; 39(1):63-71. PubMed ID: 2167692 [TBL] [Abstract][Full Text] [Related]
6. Cholecystokinin peptides and receptors in the rat brain during stress. Harro J; Löfberg C; Rehfeld JF; Oreland L Naunyn Schmiedebergs Arch Pharmacol; 1996 Jun; 354(1):59-66. PubMed ID: 8832589 [TBL] [Abstract][Full Text] [Related]
7. Neuropharmacology of a new potential anxiolytic compound, F 2692, 1-(3'-trifluoromethyl phenyl) 1, 4-dihydro 3-amino 4-oxo 6-methyl pyridazine. 2. Evaluation of its tolerance and dependence producing potential and of its effects on benzodiazepine withdrawal in the elevated plus-maze test in rats. Chopin P; Assié MB; Briley M Psychopharmacology (Berl); 1993; 110(1-2):19-26. PubMed ID: 7870883 [TBL] [Abstract][Full Text] [Related]
8. The ontogeny of benzodiazepine receptors in selected regions of the rat brain: effect of perinatal exposure to diazepam. Rothe T; Bigl V Neuropharmacology; 1989 May; 28(5):503-8. PubMed ID: 2542836 [TBL] [Abstract][Full Text] [Related]
9. [Effect of GB-115 dipeptide on anxiety in rats with model benzodiazepine withdrawal syndrome]. Kolik LG; Kadnikov IA; Zhukov VN; Gudasheva TA; Seredenin SB Eksp Klin Farmakol; 2011; 74(10):7-11. PubMed ID: 22238979 [TBL] [Abstract][Full Text] [Related]
10. Analysis of strain difference in behavior to Cholecystokinin (CCK) receptor mediated drugs in PVG hooded and Sprague-Dawley rats using elevated plus-maze test apparatus. Farook JM; Zhu YZ; Wang Q; Moochhala SM; Lee L; Wong PT Neurosci Lett; 2004 Apr; 358(3):215-9. PubMed ID: 15039119 [TBL] [Abstract][Full Text] [Related]
11. Age-related differences of cholecystokinin receptor binding in the rat brain. Harro J; Oreland L Prog Neuropsychopharmacol Biol Psychiatry; 1992 May; 16(3):369-75. PubMed ID: 1317043 [TBL] [Abstract][Full Text] [Related]
12. Different molecular forms of cholecystokinin and CCKB receptor binding in the rat brain after chronic antidepressant treatment. Harro J; Löfberg C; Pähkla R; Matto V; Rägo L; Oreland L; Allikmets L Naunyn Schmiedebergs Arch Pharmacol; 1997 Jan; 355(1):57-63. PubMed ID: 9007843 [TBL] [Abstract][Full Text] [Related]
13. The effects of cholecystokinin A and B receptor antagonists on exploratory behaviour in the elevated zero-maze in rat. Matto V; Harro J; Allikmets L Neuropharmacology; 1997 Mar; 36(3):389-96. PubMed ID: 9175618 [TBL] [Abstract][Full Text] [Related]
14. Behavioral differences in an elevated plus-maze: correlation between anxiety and decreased number of GABA and benzodiazepine receptors in mouse cerebral cortex. Rägo L; Kiivet RA; Harro J; Pŏld M Naunyn Schmiedebergs Arch Pharmacol; 1988 Jun; 337(6):675-8. PubMed ID: 2851107 [TBL] [Abstract][Full Text] [Related]
15. Cholecystokinin receptor binding after long-term ethanol treatment in rats. Harro J; Wahlström G; Oreland L Alcohol Alcohol; 1994 Sep; 29(5):575-81. PubMed ID: 7811341 [TBL] [Abstract][Full Text] [Related]
16. Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity. Hughes J; Boden P; Costall B; Domeney A; Kelly E; Horwell DC; Hunter JC; Pinnock RD; Woodruff GN Proc Natl Acad Sci U S A; 1990 Sep; 87(17):6728-32. PubMed ID: 1975695 [TBL] [Abstract][Full Text] [Related]
17. Precipitated withdrawal in squirrel monkeys after repeated daily oral administration of alprazolam, diazepam, flunitrazepam or oxazepam. Martin JR; Moreau JL; Jenck F Psychopharmacology (Berl); 1995 Apr; 118(3):273-9. PubMed ID: 7617819 [TBL] [Abstract][Full Text] [Related]
18. Benzodiazepines increase preprocholecystokinin messenger RNA levels in rat brain. Rattray M; Singhvi S; Wu PY; Andrews N; File SE Eur J Pharmacol; 1993 Apr; 245(2):193-6. PubMed ID: 8491257 [TBL] [Abstract][Full Text] [Related]
19. Anxiolytic effects of CCK-B antagonists. Costall B; Domeney AM; Hughes J; Kelly ME; Naylor RJ; Woodruff GN Neuropeptides; 1991 Jul; 19 Suppl():65-73. PubMed ID: 1679211 [TBL] [Abstract][Full Text] [Related]
20. Social isolation of rats increases the density of cholecystokinin receptors in the frontal cortex and abolishes the anti-exploratory effect of caerulein. Vasar E; Peuranen E; Harro J; Lang A; Oreland L; Männistö PT Naunyn Schmiedebergs Arch Pharmacol; 1993 Jul; 348(1):96-101. PubMed ID: 8397343 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]